As anyone in the biotech & pharma community can attest, navigating this past years’ challenging economy has not been for the faint of heart. It seems every day, there is another company reluctantly compelled to reduce its workforce in order to extend financial runways and remain viable. On the other hand, there are startups who were ready to scale, but have had to implement hiring freezes given the on-going uncertainty of when things will improve.
Vacancies leave their mark, as many companies have had to either part ways with exceptional employees or delay in hiring for roles in charge of core functions and operations. This in turn puts a significant strain on the ability to meet timely deadlines and deliver on the goals set forth to raise series funding, file for IND, or reach the clinic.
Prime Cytometry, LLC strives to help fill some of those gaps left in the wake by providing highly specialized and tailored flow cytometry and single-cell profiling services on a contract or per diem basis. This enables companies to hire the expertise necessary to maintain these critical functions to achieve their lofty goals without the budgetary constraints on full-time employment under these current economic conditions.
As we all look forward to brighter days ahead, it’s important to realize that there’s opportunity to be found even in the most trying of times.
If your company has been impacted by a recent reduction in force, or are a startup not ready to fully employ a specialist role, yet rely upon flow cytometry and single-cell services to advance your science, don’t hesitate to reach out so that we can partner together and find the solutions necessary to meet your needs!
Adam Chicoine
Founder
